Multi-layer molecular profiling defines an immune-active colorectal cancer subtype with therapeutic relevance.

Mol Ther Nucleic Acids · 2026 · PMC13068838 · PMID 41971068

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

an increasing trendno p-value reported

In contrast, those with partial response (PR) or stable disease (SD) displayed lower baseline activity, with an increasing trend during therapy, potentially reflecting delayed or suboptimal immune engagement ( Figures 6 D and 6E).

also in 63,971 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.